Thromboembolic risk evaluation in patients with atrial fibrillation using a modified CHADS 2 scoring system

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 2, 2012, Pages 155-162

  Cha, Myung Jin ^a   Oh, Gyu Chul ^a   Hahn, Seokyung ^a   Choi, Eue Keun ^a   Oh, Seil ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

anticoagulation; antithrombotic treatment; atrial fibrillation; CHA 2DS 2 VASc score; CHADS 2 score; stroke

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM;

EID: 84857035619     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02181.x     Document Type: Article

References (25)

1. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
2. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ,: Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870. (Pubitemid 32537350)
3. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Jr., Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A,: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-2150. (Pubitemid 33028911)
4. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL,: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with The European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354. (Pubitemid 44252297)
5. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E,: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet 2007; 370: 493-503. (Pubitemid 47212371)
6. Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS,: A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 2007; 36: 151-156. (Pubitemid 46455393)
7. Lee BH, Park JS, Park JH, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN,: The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1. J Cardiovasc Electrophysiol 2010; 21: 501-507.
8. 2 score of 1. J Cardiovasc Electrophysiol 2010; 21: 508-510.
9. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S,: Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy. Lancet 1996; 348: 423-428. (Pubitemid 26267872)
10. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D,: Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol 2009; 54: 999-1002.
11. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE,: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-1026. (Pubitemid 37087616)
12. Landefeld CS, Goldman L,: Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 144-152. (Pubitemid 19201634)
13. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS,. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation 2005; 112: 1687-1691. (Pubitemid 41368143)
14. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW,: Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF i-iii clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999; 30: 1223-1229. (Pubitemid 29259178)
15. Investigators AF,: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized clinical trials. Arch Intern Med 1994; 154: 1449-1457.
16. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ,. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 2003; 290: 1049-1056. (Pubitemid 37430445)
17. van Walraven C HR, Wells GA, et al: A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003; 163: 936-943. (Pubitemid 36519739)
18. Schmitt J, Duray G, Gersh BJ, Hohnloser SH,: Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-1045.
19. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA,: Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-257. (Pubitemid 27044626)
20. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE,: Antithrombotic therapy in atrial fibrillation. Chest 2001; 119: 194S-206S. (Pubitemid 32154200)
21. Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, Singer DE,: Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation 2009; 119: 1363-1369.
22. Khella SL,: New insights into stroke in chronic kidney disease. Adv Chronic Kidney Dis 2008; 15: 338-346.
23. Seliger SL GD, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO,: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003; 64: 603-609. (Pubitemid 36871932)
24. Audebert HJ, Schenk B, Schenkel J, Heuschmann PU,: Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation. Cerebrovasc Dis 2010; 29: 476-483.
25. Baker WL, Cios DA, Sander SD, Coleman CI,: Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the united states. J Manag Care Pharm 2009; 15: 244-252.